Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe Towards a common nomenclature

Abstract : Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail. In vitro, most VRE remain susceptible to last-resort antibiotics such as linezolid, tigecycline and daptomycin. However, neither tigecycline nor linezolid act in a bactericidal manner, and daptomycin has proven activity only at high dosages licensed for treating enterococcal endocarditis. Despite these pharmacological and therapeutic limitations, reports on resistance to these last-resort drugs in VRE, and enterococci in general, have increased in recent years. In this review, we briefly recapitulate the current knowledge on the mode of action as well as the known and novel mechanisms of resistance and describe surveillance data on resistance to linezolid, tigecycline and daptomycin in enterococci. In addition, we also suggest a common nomenclature for designating enterococci and VRE with resistances to these important last-resort antibiotics.
Document type :
Journal articles
Complete list of metadatas

Cited literature [198 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01940265
Contributor : Laurent Jonchère <>
Submitted on : Monday, December 3, 2018 - 1:30:13 PM
Last modification on : Wednesday, June 12, 2019 - 3:30:03 PM
Long-term archiving on : Monday, March 4, 2019 - 2:23:15 PM

File

Bender et al_2018_Update on pr...
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Citation

Jennifer K Bender, Vincent Cattoir, Kristin Hegstad, Ewa Sadowy, Teresa M Coque, et al.. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe Towards a common nomenclature. Drug Resistance Updates, Elsevier, 2018, 40, pp.25-39. ⟨10.1016/j.drup.2018.10.002⟩. ⟨hal-01940265⟩

Share

Metrics

Record views

36

Files downloads

175